Search research articles
Contact Us
Filters
Showing results (711-720 of 811) with videos related to
Page
of 82
Sort By:
Journal for Immunotherapy of Cancer
|
March 15, 2019
Collagen density regulates the activity of tumor-infiltrating T cells
Dorota E Kuczek, Anne Mette H Larsen, Marie-Louise Thorseth, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial
Renske M T Ten Ham, Maartje W Rohaan, Inge Jedema, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 22, 2023
"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care
M D Egeler, E Boomstra, M W Rohaan, et al.
American Journal of Industrial Medicine
|
December 21, 2002
Estimating exposures in the asphalt industry for an international epidemiological cohort study of cancer risk
Igor Burstyn, Paolo Boffetta, Timo Kauppinen, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells
Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 10, 2024
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study
Stine K Christensen, Mette L Winther, Ida J Laursen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2023
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)
Inna M Chen, Marco Donia, Christopher A Chamberlain, et al.
American Journal of Epidemiology
|
August 26, 2003
Mortality from obstructive lung diseases and exposure to polycyclic aromatic hydrocarbons among asphalt workers
Igor Burstyn, Paolo Boffetta, Dick Heederik, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2021
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Troels Holz Borch, Katja Harbst, Aynal Haque Rana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
Alice Markussen, Julia S Johansen, Finn O Larsen, et al.
Page
of 82
Search research articles
Search
Showing results (711-720 of 811) with videos related to
Sort By:
Page
of 82
Journal for Immunotherapy of Cancer
|
March 15, 2019
Collagen density regulates the activity of tumor-infiltrating T cells
Dorota E Kuczek, Anne Mette H Larsen, Marie-Louise Thorseth, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial
Renske M T Ten Ham, Maartje W Rohaan, Inge Jedema, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 22, 2023
"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care
M D Egeler, E Boomstra, M W Rohaan, et al.
American Journal of Industrial Medicine
|
December 21, 2002
Estimating exposures in the asphalt industry for an international epidemiological cohort study of cancer risk
Igor Burstyn, Paolo Boffetta, Timo Kauppinen, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells
Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 10, 2024
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study
Stine K Christensen, Mette L Winther, Ida J Laursen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2023
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)
Inna M Chen, Marco Donia, Christopher A Chamberlain, et al.
American Journal of Epidemiology
|
August 26, 2003
Mortality from obstructive lung diseases and exposure to polycyclic aromatic hydrocarbons among asphalt workers
Igor Burstyn, Paolo Boffetta, Dick Heederik, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2021
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Troels Holz Borch, Katja Harbst, Aynal Haque Rana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
Alice Markussen, Julia S Johansen, Finn O Larsen, et al.
Page
of 82